SOLESENCE, INC.: WHITMORE BRADFORD T amends Schedule 13D stake filing

Whitmore Bradford T filed an amended Schedule 13D with the SEC (accession 0000933430-26-000007) covering its stake in Solesence, Inc. The amendment updates the investor's previously reported beneficial ownership position in the skincare ingredients maker. The filing does not disclose a change in control or a new activist campaign on its face, but 13D amendments are closely watched for shifts in intent. Investors should watch for further filings or disclosures clarifying whether Whitmore Bradford T has added to, trimmed, or otherwise adjusted its position.